Literature DB >> 10865204

Does suppression of bone turnover impair mechanical properties by allowing microdamage accumulation?

T Hirano1, C H Turner, M R Forwood, C C Johnston, D B Burr.   

Abstract

One plausible purpose of bone turnover is to repair bone microdamage. We hypothesized that suppression of bone turnover impairs bone quality by allowing accumulation of microdamage. We investigated the effect of high-dose etidronate (EHDP) on bone's mechanical properties and microdamage accumulation. Skeletally mature beagles, 1-2 years old at the beginning of the study, were treated with daily injections of vehicle or EHDP at 0.5 mg/kg per day or 5.0 mg/kg per day for 1 year. X-rays were taken at baseline and monthly from 7 to 12 months. Bones were taken upon sacrifice and biomechanical tests, histomorphometry, and microdamage analyses were performed. Fractures of ribs and/or thoracic spinous processes were found in 10 of 11 dogs treated with the higher dose EHDP. Only one fracture of a thoracic spinous process was found in dogs treated with the lower dose EHDP, and no fractures were found in the vehicle controls. Biomechanical tests showed reduced mechanical strength in ribs and lumbar vertebrae, but not in the femoral diaphysis or thoracic spinous process in the higher dose EHDP group. Histomorphometric measurements showed a significant reduction of cancellous bone turnover in both EHDP-treated groups compared with controls. In dogs treated with the higher dose EHDP, activation frequency was reduced to zero in both cortical and cancellous bone. Osteoid volume increased significantly, especially in trabecular bone, resulting in reduced mineralized bone volume in the higher dose EHDP group. Microcrack numerical density (Cr.Dn) increased significantly only in the lumbar vertebral body in the higher dose EHDP group, but not in the rib or thoracic spinous process where fractures occurred. These findings show that suppression of bone turnover using high doses of EHDP is associated with fractures of the ribs and spinous processes in dogs. This is most likely the result of excessive amounts of unmineralized bone produced by the inhibition of mineralization at these high doses, rather than by the accumulation of microdamage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10865204     DOI: 10.1016/s8756-3282(00)00284-2

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  24 in total

Review 1.  Aging and bone.

Authors:  A L Boskey; R Coleman
Journal:  J Dent Res       Date:  2010-10-05       Impact factor: 6.116

Review 2.  Microdamage and bone strength.

Authors:  David Burr
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

Review 3.  The aging cortex: to crack or not to crack.

Authors:  Karl J Jepsen
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

Review 4.  Microcracks in cortical bone: how do they affect bone biology?

Authors:  Fergal J O'Brien; Orlaith Brennan; Oran D Kennedy; T Clive Lee
Journal:  Curr Osteoporos Rep       Date:  2005-06       Impact factor: 5.096

Review 5.  The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future.

Authors:  Samantha Pozzi; Noopur Raje
Journal:  Oncologist       Date:  2011-04-14

Review 6.  The effect of antiresorptives on bone quality.

Authors:  Robert R Recker; Laura Armas
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

7.  Case report of spontaneous, nonspinal fractures in a multiple myeloma patient on long-term pamidronate and zoledronic acid.

Authors:  Greg Wernecke; Surena Namdari; Surena Namduri; Edward F DiCarlo; Robert Schneider; Joseph Lane
Journal:  HSS J       Date:  2008-07-16

8.  Heritability of lumbar trabecular bone mechanical properties in baboons.

Authors:  L M Havill; M R Allen; T L Bredbenner; D B Burr; D P Nicolella; C H Turner; D M Warren; M C Mahaney
Journal:  Bone       Date:  2009-11-10       Impact factor: 4.398

9.  Theoretical analysis of alendronate and risedronate effects on canine vertebral remodeling and microdamage.

Authors:  Xiang Wang; Antonia M Erickson; Matthew R Allen; David B Burr; R Bruce Martin; Scott J Hazelwood
Journal:  J Biomech       Date:  2009-03-12       Impact factor: 2.712

10.  Identification and treatment of osteoporosis among elderly patients with hip fractures.

Authors:  Erika Satomi; Maria do Carmo Sitta; Adriana Nunes Machado; Luiz Eugênio Garcez Leme
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.